Skip to Content

WPI 2344 (Lacosamide 150 mg)

Pill with imprint WPI 2344 is Brown, Elliptical / Oval and has been identified as Lacosamide 150 mg. It is supplied by Actavis Pharma, Inc..

Lacosamide is used in the treatment of epilepsy; seizures and belongs to the drug class miscellaneous anticonvulsants. Risk cannot be ruled out during pregnancy. Lacosamide 150 mg is classified as a Schedule 5 controlled substance under the Controlled Substance Act (CSA).

Images for WPI 2344

Lacosamide

Imprint
WPI 2344
Strength
150 mg
Color
Brown
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Miscellaneous anticonvulsants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
5 - Some potential for abuse
Labeler / Supplier
Actavis Pharma, Inc.
National Drug Code (NDC)
00591-2344

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.